Pubertad precoz

Referencias

Artículos principales

Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969 Jun;44(235):291-303.Texto completo  Resumen

Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970 Feb;45(239):13-23.Texto completo  Resumen

Zacharin M. The spectrum of McCune Albright syndrome. Pediatr Endocrinol Rev. 2007 Aug;4(suppl 4):412-8. Resumen

Carel JC, Eugster EA, Rogol A, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009 Apr;123(4):e752-62. Resumen

Artículos de referencia

1. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969 Jun;44(235):291-303.Texto completo  Resumen

2. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970 Feb;45(239):13-23.Texto completo  Resumen

3. Cesario SK, Hughes LA. Precocious puberty: a comprehensive review of literature. J Obstet Gynecol Neonatal Nurs. 2007 May-Jun;36(3):263-74. Resumen

4. Bridges NA, Christopher JA, Hindmarsh PC, et al. Sexual precocity: sex incidence and aetiology. Arch Dis Child. 1994 Feb;70(2):116-8.Texto completo  Resumen

5. Pescovitz OH, Comite F, Hench K, et al. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. J Pediatr. 1986 Jan;108(1):47-54. Resumen

6. Stanhope R, Brook CG, Pringle PJ, et al. Induction of puberty by pulsatile gonadotropin releasing hormone. Lancet. 1987 Sep 5;2(8558):552-5. Resumen

7. Biro FM, Galvez MP, Greenspan LC, et al. Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls. Pediatrics. 2010 Sep;126(3):e583-90.Texto completo  Resumen

8. Tanner JM. Trend towards earlier menarche in London, Oslo, Copenhagen, the Netherlands and Hungary. Nature. 1973 May 11;243(5402):95-6. Resumen

9. Biro FM, Khoury P, Morrison JA. Influence of obesity on timing of puberty. Int J Androl. 2006 Feb;29(1):272-7. Resumen

10. Delemarre-van de Waal HA. Secular trend of timing of puberty. Endocr Dev. 2005;8:1-14. Resumen

11. de la Puente ML, Canela J, Alvarez J, et al. Cross-sectional growth study of the child and adolescent population of Catalonia (Spain). Ann Hum Biol. 1997 Sep-Oct;24(5):435-52. Resumen

12. Mul D, Fredriks AM, van Buuren S, et al. Pubertal development in The Netherlands 1965-1997. Pediatr Res. 2001 Oct;50(4):479-86. Resumen

13. Himes JH. Examining the evidence for recent secular changes in the timing of puberty in US children in light of increases in the prevalence of obesity. Mol Cell Endocrinol. 2006 Jul 25;254-255:13-21. Resumen

14. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA. 2008 May 28;299(20):2401-5.Texto completo  Resumen

15. Osler DC, Crawford JD. Examination of the hypothesis of a critical weight at menarche in ambulatory and bedridden mentally retarded girls. Pediatrics. 1973 Apr;51(4):675-9. Resumen

16. Massart F, Parrino R, Seppia P, et al. How do environmental estrogen disruptors induce precocious puberty? Minerva Pediatr. 2006 Jun;58(3):247-54. Resumen

17. Habiby R, Silverman B, Listernick R, et al. Precocious puberty in children with neurofibromatosis type 1. J Pediatr. 1995 Mar;126(3):364-7. Resumen

18. Carmi D, Shohat M, Metzker A, et al. Growth, puberty, and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: a longitudinal study. Pediatrics. 1999 Jun;103(6 Pt 1):1257-62. Resumen

19. Teles MG, Bianco SD, Brito VN, et al. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med. 2008 Feb 14;358(7):709-15.Texto completo  Resumen

20. Nanduri VR, Stanhope R. Why is the retention of gonadotropin secretion common in children with panhypopituitarism due to septo-optic dysplasia? Eur J Endocrinol. 1999 Jan;140(1):48-50.Texto completo  Resumen

21. Parent AS, Teilmann G, Juul A, et al. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev. 2003 Oct;24(5):668-93.Texto completo  Resumen

22. Proos LA, Hofvander Y, Tuvemo T. Menarcheal age and growth pattern of Indian girls adopted in Sweden - I: menarcheal age. Acta Paediatr Scand. 1991 Aug-Sep;80(8-9):852-8. Resumen

23. Herman-Giddens ME, Sandler AD, Friedman NE. Sexual precocity in girls: an association with sexual abuse? Am J Dis Child. 1988 Apr;142(4):431-3. Resumen

24. Nogueira K, Liberman B, Pimentel-Filho FR, et al. hCG-secreting pineal teratoma causing precocious puberty: report of two patients and review of the literature. J Pediatr Endocrinol Metab. 2002 Sep-Oct;15(8):1195-201. Resumen

25. Ojeda SR, Lomniczi A, Mastronardi C, et al. Minireview: the neuroendocrine regulation of puberty: is the time ripe for a systems biology approach? Endocrinology. 2006 Mar;147(3):1166-74.Texto completo  Resumen

26. Martha PM Jr, Rogol AD, Veldhuis JD, et al. Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys. J Clin Endocrinol Metab. 1989 Sep;69(3):563-70. Resumen

27. Veldhuis JD, Metzger DL, Martha PM Jr, et al. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab. 1997 Oct;82(10):3414-20. Resumen

28. Ogilvy-Stuart AL, Clayton PE, Shalet SM. Cranial irradiation and early puberty. J Clin Endocrinol Metab. 1994 Jun;78(6):1282-6. Resumen

29. Zacharin M. The spectrum of McCune Albright syndrome. Pediatr Endocrinol Rev. 2007 Aug;4(suppl 4):412-8. Resumen

30. Volkl TM, Dorr HG. McCune-Albright syndrome: clinical picture and natural history in children and adolescents. J Pediatr Endocrinol Metab. 2006 May;19(suppl 2):551-9. Resumen

31. Mieszczak J, Eugster EA. Treatment of precocious puberty in McCune-Albright syndrome. Pediatr Endocrinol Rev. 2007 Aug;4(suppl 4):419-22. Resumen

32. Latronico AC, Abell AN, Arnhold IJ, et al. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab. 1998 Jul;83(7):2435-40. Resumen

33. Kremer H, Martens JW, van Reen M, et al. A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. J Clin Endocrinol Metab. 1999 Mar;84(3):1136-40. Resumen

34. Hayes P. International adoption, "early" puberty, and underrecorded age. Pediatrics. 2013 Jun;131(6):1029-31. Resumen

35. Jung H, Parent AS, Ojeda SR. Hypothalamic hamartoma: a paradigm/model for studying the onset of puberty. Endocr Dev. 2005;8:81-93. Resumen

36. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952 Apr;40(4):423-41. Resumen

37. Mahachoklertwattana P, Kaplan SL, Grumbach MM. The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab. 1993 Jul;77(1):118-24. Resumen

38. Kaplowitz PB. Do 6-8 year old girls with central precocious puberty need routine brain imaging? Int J Pediatr Endocrinol. 2016 May 4;2016:9.Texto completo  Resumen

39. Lewis KA, Goldyn AK, West KW, et al. A single histrelin implant is effective for 2 years for treatment of central precocious puberty. J Pediatr. 2013 Oct;163(4):1214-6.Texto completo  Resumen

40. Eugster EA, Clarke W, Kletter GB, et al. Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial. J Clin Endocrinol Metab. 2007 May;92(5):1697-704. Resumen

41. Hirsch HJ, Gillis D, Strich D, et al. The histrelin implant: a novel treatment for central precocious puberty. Pediatrics. 2005 Dec;116(6):e798-802.Texto completo  Resumen

42. Tuvemo T. Treatment of central precocious puberty. Expert Opin Investig Drugs. 2006 May;15(5):495-505. Resumen

43. Galluzzi F, Salti R, Bindi G, et al. Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy. Acta Paediatr. 1998 May;87(5):521-7. Resumen

44. Paul D, Conte FA, Grumbach MM, et al. Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab. 1995 Feb;80(2):546-51. Resumen

45. Kletter GB, Kelch RP. Clinical review 60: effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab. 1994 Aug;79(2):331-4. Resumen

46. Carel JC, Eugster EA, Rogol A, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009 Apr;123(4):e752-62. Resumen

47. Carel JC, Lahlou N, Roger M, et al. Precocious puberty and statural growth. Hum Reprod Update. 2004 Mar-Apr;10(2):135-47.Texto completo  Resumen

48. Kaplowitz PB, Backeljauw PF, Allen DB. Toward more targeted and cost-effective gonadotropin-releasing hormone analog treatment in girls with central precocious puberty. Horm Res Paediatr. 2018;90(1):1-7.Texto completo  Resumen

49. Saggese G, Bertelloni S, Baroncelli GI, et al. Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty. Eur J Pediatr. 1993 Sep;152(9):717-20. Resumen

50. Syed FA, Chalew SA. Ketoconazole treatment of gonadotropin independent precocious puberty in girls with McCune-Albright syndrome: a preliminary report. J Pediatr Endocrinol Metab. 1999 Jan-Feb;12(1):81-3. Resumen

51. Feuillan PP, Foster CM, Pescovitz OH, et al. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med. 1986 Oct 30;315(18):1115-9. Resumen

52. Feuillan P, Calis K, Hill S, et al. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study. J Clin Endocrinol Metab. 2007 Jun;92(6):2100-6. Resumen

53. Kreher NC, Pescovitz OH, Delameter P, et al. Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. J Pediatr. 2006 Sep;149(3):416-20. Resumen

54. Feuillan P, Merke D, Leschek EW, et al. Use of aromatase inhibitors in precocious puberty. Endocr Relat Cancer. 1999 Jun;6(2):303-6.Texto completo  Resumen

55. Leschek EW, Jones J, Barnes KM, et al. Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset. J Clin Endocrinol Metab. 1999 Jan;84(1):175-8. Resumen

56. Laue L, Kenigsberg D, Pescovitz OH, et al. Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med. 1989 Feb 23;320(8):496-502. Resumen

57. European Medicines Agency. Ketoconazole-containing medicines. October 2013 [internet publication].Texto completo

58. European Medicines Agency. European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole. July 2013. http://www.ema.europa.eu/ema/ [internet publication].Texto completo

59. Lee PA. Medroxyprogesterone therapy for sexual precocity in girls. Am J Dis Child. 1981 May;135(5):443-5. Resumen

60. Eugster EA, Rubin SD, Reiter EO, et al. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr. 2003 Jul;143(1):60-6. Resumen

61. Cook DM, Yuen KC, Biller BM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update. Endocr Pract. 2009 Sep-Oct;15(suppl 2):1-29.Texto completo  Resumen

62. GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab. 2000 Nov;85(11):3990-3.Texto completo  Resumen

63. Paterson WF, McNeill E, Young D, et al. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Clin Endocrinol (Oxf). 2004 Nov;61(5):626-34. Resumen

64. Paterson WF, Hollman AS, Reid S, et al. Efficacy of Zoladex LA (goserelin) in the treatment of girls with central precocious or early puberty. Arch Dis Child. 1998 Oct;79(4):323-7.Texto completo  Resumen

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad